Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
R Meyer-Schwickerath, … , R Röllmann, H Schatz
R Meyer-Schwickerath, … , R Röllmann, H Schatz
Published December 1, 1993
Citation Information: J Clin Invest. 1993;92(6):2620-2625. https://doi.org/10.1172/JCI116877.
View: Text | PDF
Research Article Article has an altmetric score of 3

Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.

  • Text
  • PDF
Abstract

Retinal capillary nonperfusion results in neovascularization of the eye, which is restricted to the retina in less severe cases and progresses to the anterior chamber and the iris angle in the most advanced case, called rubeosis. This angioneogenesis may be induced by the release of retinal growth factors into the vitreous. This study compared levels of the IGF-I and IGF-II, and of the IGF binding protein-2 (IGFBP-2) and IGFBP-3 in vitreous from three groups with different degrees of retinal ischemia, as judged by the extent of neovascularization: a control group without new vessel formation, retinal neovascularization in patients with proliferative diabetic retinopathy, and massive ischemia of various causes resulting in rubeosis. IGF-I and IGFBP-3 were increased 10- and 13-fold in rubeosis (P << 0.01) compared with no ischemia (n = 10), while IGF-II and IGFBP-2 were elevated 2.7- and 4.3-fold (P < 0.01). Within the rubeosis group similar changes were observed independently of the cause of ischemia, which was central vein occlusion, ischemic ophthalmopathy, or intraocular tumor in seven cases and diabetic retinopathy in three samples from two patients. Vitreous from patients with proliferative diabetic retinopathy but without rubeosis (n = 16) contained 2.5- and 2.2-fold elevated levels of IGF-I and of IGFBP-2 (P < 0.05), while IGF-II and IGFBP-3 were increased 1.4- and 1.6-fold, which was not significant. We conclude that: (a) ischemia appears to be a strong stimulus for the local production of IGF-I and -II and of IGFBP-2 and -3 in the eye. (b) Changes in IGF-I and IGFBP-2 in proliferative diabetic retinopathy may be secondary to local ischemia rather than being specific for diabetic retinopathy. (c) IGF-I and IGFBP-3 may play a role in mediating angioneogenesis in the eye.

Authors

R Meyer-Schwickerath, A Pfeiffer, W F Blum, H Freyberger, M Klein, C Lösche, R Röllmann, H Schatz

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1990 1964 Total
Citations: 3 2 3 3 2 1 5 1 2 2 2 9 3 7 3 3 5 11 3 4 7 3 4 12 5 4 2 11 12 2 4 1 1 142
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (144)

Title and authors Publication Year
Single‐cell RNA sequencing in exploring the pathogenesis of diabetic retinopathy
Zhang X, Zhang F, Xu X
Clinical and Translational Medicine 2024
Blood Glucose Levels Moderate the Associations Between IGF-1 Levels and Choroidal Metrics in Patients With Diabetes With Acromegaly Without Diabetic Retinopathy
Zhang X, Wang H, Zhang K, Ma J, He H, Song S, Shao E, Chen B, Yang J, Zhao X, Sui W, Wang M, Liu S, Guo X, Zhu H, Yao Y, Zhong Y, Xing B
Translational Vision Science & Technology 2024
Eye on the horizon: The metabolic landscape of the RPE in aging and disease
Hansman DS, Du J, Casson RJ, Peet DJ
Progress in retinal and eye research 2024
Progress in Research on Stem Cells in Neonatal Refractory Diseases.
Huang F, He Y, Zhang M, Luo K, Li J, Li J, Zhang X, Dong X, Tang J
Journal of Personalized Medicine 2023
Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy.
Li J, Chen K, Li X, Zhang X, Zhang L, Yang Q, Xia Y, Xie C, Wang X, Tong J, Shen Y
Cell Death Discovery 2023
PAI-1 is a vascular cell–specific HIF-2–dependent angiogenic factor that promotes retinal neovascularization in diabetic patients
Y Qin, J Zhang, S Babapoor-Farrokhran, B Applewhite, M Deshpande, H Megarity, M Flores-Bellver, S Aparicio-Domingo, T Ma, Y Rui, S Tzeng, J Green, M Canto-Soler, S Montaner, A Sodhi
Science Advances 2022
Retinal Transcriptome and Cellular Landscape in Relation to the Progression of Diabetic Retinopathy
Wang JH, Wong RC, Liu GS
Investigative ophthalmology & visual science 2022
Deletion of Tgfβ signal in activated microglia prolongs hypoxia‐induced retinal neovascularization enhancing Igf1 expression and retinal leukostasis
Usui\u2010Ouchi A, Eade K, Giles S, Ideguchi Y, Ouchi Y, Aguilar E, Wei G, Marra KV, Berlow RB, Friedlander M
Glia 2022
Diabetic retinal neurodegeneration as a form of diabetic retinopathy
D Soni, P Sagar, B Takkar
International Ophthalmology 2021
Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration.
Huber AL, Angermann R, Nowosielski Y, Seifarth C, Kralinger MT, Zehetner C
Journal of Ophthalmology 2021
Optical coherence tomography in patients with somatotropin-producing pituitary adenoma
NA Gavrilova, NS Gadzhieva, AV Kuzmina
2021
Efficacy and safety of Chinese medicines for vitreous hemorrhage: A protocol for systematic review and meta-analysis
M Han, Z Liu, L Nong, Y Zi, H Meng, Y Deng, ZJ Wang, M Jin
Medicine 2020
Iris thickness measurements in patients with diabetic retinopathy
Ö Demirtas, G Pekel, E Pekel, EN Cetin
European journal of ophthalmology 2020
The tear VEGF and IGFBP3 in healthy and diabetic retinopathy
M Sheikhrezaee, MR Alizadeh, S Abediankenari
International Journal of Diabetes in Developing Countries 2019
Somatolactogens and diabetic retinopathy
KC Bermea, A Rodríguez-García, A Tsin, HA Barrera-Saldaña
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2018
Role of Inflammation in Diabetic Retinopathy
A Rübsam, S Parikh, P Fort
International journal of molecular sciences 2018
Mousetap, a Novel Technique to Collect Uncontaminated Vitreous or Aqueous and Expand Usefulness of Mouse Models
SD Fortmann, VE Lorenc, J Shen, SF Hackett, PA Campochiaro
Scientific Reports 2018
Intraocular Hemorrhage due to use of Sildenafil in a Patient with Diabetes
Cagri Ilhan, Mehmet Murat Uzel, Mehmet Citirik
Medical hypothesis, discovery and innovation in ophthalmology 2018
Early worsening of diabetic retinopathy due to intensive glycaemic control
SW Lim, P van Wijngaarden, CA Harper, SH Al-Qureshi
Clinical & Experimental Ophthalmology 2018
Gene expression levels of the insulin-like growth factor family in patients with AMD before and after ranibizumab intravitreal injections
B Strzalka-Mrozik, M Kimsa-Furdzik, A Kabiesz, K Michalska-Małecka, M Nita, U Mazurek
Clinical Interventions in Aging 2017
Retinal fibrosis in diabetic retinopathy
S Roy, S Amin, S Roy
Experimental Eye Research 2016
The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
C Alagöz, Y Yıldırım, M Kocamaz, Ö Baz, U Çiçek, B Çelik, Hİ Demirkale, AT Yazıcı, M Taşkapılı
Türk Oftalmoloji Dergisi 2016
Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival
J Ma, C Guo, C Guo, Y Sun, T Liao, U Beattie, FJ López, DF Chen, K Lashkari, G Chidlow
PloS one 2015
Association Between Diabetic Macular Edema and Cardiovascular Events in Type 2 Diabetes Patients: A Multicenter Observational Study
N Leveziel, S Ragot, E Gand, O Lichtwitz, JM Halimi, J Gozlan, P Gourdy, MF Robert, D Dardari, M Boissonnot, R Roussel, X Piguel, O Dupuy, F Torremocha, PJ Saulnier, R Maréchaud, S Hadjadj
Medicine 2015
TGF-β1 and IGF-I gene variations in type 1 diabetes microangiopathic complications
J Bazzaz, MM Amoli, Z Taheri, B Larijani, V Pravica, IV Hutchinson
Journal of Diabetes & Metabolic Disorders 2014
Insulin-like growth factor-II: its role in metabolic and endocrine disease
C Livingstone, A Borai
Clinical Endocrinology 2014
An ocular view of the IGF-IGFBP system
DV Nguyen, SL Calzi, LC Shaw, JL Kielczewski, HE Korah, MB Grant
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2013
Gene expression of IGF1, IGF1R, and IGFBP3 in epiretinal membranes of patients with proliferative diabetic retinopathy: preliminary study
D Romaniuk, MW Kimsa, B Strzalka-Mrozik, MC Kimsa, A Kabiesz, W Romaniuk, U Mazurek
Mediators of Inflammation 2013
Pathophysiology of Diabetic Retinopathy
JM Tarr, K Kaul, M Chopra, EM Kohner, R Chibber
ISRN Ophthalmology 2013
Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells
HL Deissler, H Deissler, GK Lang, GE Lang
Graefe's Archive for Clinical and Experimental Ophthalmology 2013
Retina
G Staurenghi, F Bottoni, A Giani
Retina 2013
Recent Advances in the Management of Neovascular Glaucoma
JR SooHoo, LK Seibold, MY Kahook
Seminars in Ophthalmology 2013
VEGF but not PlGF disturbs the barrier of retinal endothelial cells
HL Deissler, H Deissler, GK Lang, GE Lang
Experimental Eye Research 2013
Diabetes changes expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina
JC Lau, RA Kroes, JR Moskal, RA Linsenmeier
Molecular vision 2013
Role of the retinal vascular endothelial cell in ocular disease
A Bharadwaj, B Appukuttan, PA Wilmarth, Y Pan, AJ Stempel, TJ Chipps, EE Benedetti, DO Zamora, D Choi, LL David, JR Smith
Progress in Retinal and Eye Research 2012
Vitreous IGFBP-3 Effects on Müller Cell Proliferation and Tractional Force Generation
JL King, C Guidry
Investigative ophthalmology & visual science 2012
Anti-VEGF Therapy With Bevacizumab for Anterior Segment Eye Disease :
H Hosseini, MH Nowroozzadeh, R Salouti, M Nejabat
Cornea 2012
Disruption of IAP/SHPS-1 association inhibits pathophysiologic changes in retinal endothelial function in diabetic rats
LA Maile, K Gollahon, C Wai, G Byfield, ME Hartnett, D Clemmons
Diabetologia 2011
Compensatory Growth Factor and Cytokine Response in Tears After Subconjunctival Bevacizumab Injection :
JH Jeong, YS Chun, ES Kim, JC Kim
Cornea 2011
Williams Textbook of Endocrinology
DW Cooke, SA Divall, S Radovick
Williams Textbook of Endocrinology 2011
Serum insulin-like growth factor-I in diabetic retinopathy
JF Payne, V Tangpricha, J Cleveland, MJ Lynn, R Ray, SK Srivastava
Molecular vision 2011
Visual Dysfunction in Diabetes
J Tombran-Tink, CJ Barnstable, TW Gardner
2011
Therapeutic Angiogenesis for Vascular Diseases
M Slevin
2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Concentration of Vascular Endothelial Growth Factor After Intracameral Bevacizumab Injection in Eyes With Neovascular Glaucoma
TH Lim, SH Bae, YJ Cho, JH Lee, HK Kim, YH Sohn
Korean Journal of Ophthalmology 2009
Insulin, insulin analogues and diabetic retinopathy
E Chantelau, R Kimmerle, R Meyer-Schwickerath
Archives Of Physiology And Biochemistry 2008
Results of Intravitreal Bevacizumab for Macular Edema with Retinal Vein Occlusion and Diabetic Macular Edema
JY Kim, EY Kweon, DW Lee, NC Cho
Journal of the Korean Ophthalmological Society 2008
Glaucome néovasculaire
S Auriol, J Douat, L Mahieu, V Pagot-Mathis, A Mathis
EMC - Ophtalmologie 2008
Retinal and Choroidal Angiogenesis
JS Penn
2008
Age-Related Changes of the Human Eye
CA Cavallotti, L Cerulli
2008
The Etiology of Steroid Cataract
ER James
Journal of Ocular Pharmacology and Therapeutics 2007
Anti-Angiogenic Effects of Ribonucleic Acid Interference Targeting Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor-1α
F Forooghian, B Das
American Journal of Ophthalmology 2007
IMMUNOREACTIVE ENDOTHELIN-1 IN THE VITREOUS HUMOR AND EPIRETINAL MEMBRANES OF PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY
M Rold??N-Pallar??S, R Roll??N, JC Mart??Nez-Montero, A Fern??Ndez-Cruz, C Bravo-Llata, R Fern??Ndez-Durango
Retina 2007
Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients
T Kim, SJ Kim, K Kim, UB Kang, C Lee, KS Park, HG Yu, Y Kim
PROTEOMICS 2007
Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy
SX Zhang, J Ma
Progress in Retinal and Eye Research 2007
Transplantation of the RPE in AMD
S Binder, BV Stanzel, I Krebs, C Glittenberg
Progress in Retinal and Eye Research 2007
Geriatric Diabetes
M Burge, L Gamache, H Pai, A Segal
Geriatric Diabetes 2007
Bevacizumab in glaucoma: a review
P Ichhpujani, A Ramasubramanian, S Kaushik, SS Pandav
Canadian Journal of Ophthalmology / Journal Canadien d'Ophtalmologie 2007
Retinal Vascular Disease
AM Joussen, TW Gardner, B Kirchhof, SJ Ryan
2007
Increased Levels of Transforming Growth Factor-Beta1 and -Beta2 in the Aqueous Humor of Patients With Neovascular Glaucoma
XB Yu, XH Sun, E Dahan, WY Guo, SH Qian, FR Meng, YL Song, GJ Simon
Ophthalmic Surgery, Lasers and Imaging Retina 2007
Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance
Cristiano Alessandri, Michele Bombardieri, Guido Valesini
Advances in Clinical Chemistry 2006
Proliferating endothelial cell-specific expression of IGF-I receptor ribozyme inhibits retinal neovascularization
LC Shaw, H Pan, A Afzal, SL Calzi, PE Spoerri, SM Sullivan, MB Grant
Gene Therapy 2006
Ocular Angiogenesis
J Tombrain-Tink, CJ Barnstable
2006
Vascular Endothelial Growth Factor Levels in Vitreous and Serum of Patients with either Proliferative Diabetic Retinopathy or Proliferative Vitreoretinopathy
M Sydorova, MS Lee
Ophthalmic Research 2005
The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy
S Loukovaara, IJ Immonen, R Koistinen, EM Rutanen, V Hiilesmaa, M Loukovaara, RJ Kaaja
Journal of Diabetes and its Complications 2005
The role of Müller cells in fibrocontractive retinal disorders
C Guidry
Progress in Retinal and Eye Research 2005
The Somatotrophic Axis in Brain Function
HJ Schneider, GK Stalla
The Somatotrophic Axis in Brain Function 2005
Insulin like growth factor-1 and insulin-like growth factor binding proteins: their possible roles in both maintaining normal retinal vascular function and in promoting retinal pathology.
Shaw LC, Grant MB
Reviews in endocrine & metabolic disorders 2004
Effects of Growth-Factor Combinations on Vascular Endothelial Cell GrowthIn Vitro
WC Wu, YH Kao, CH Chung
Journal of Ocular Pharmacology and Therapeutics 2004
PEDF derived from glial Müller cells: a possible regulator of retinal angiogenesis
W Eichler, Y Yafai, T Keller, P Wiedemann, A Reichenbach
Experimental Cell Research 2004
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis
EJ Duh, HS Yang, JA Haller, ED Juan, MS Humayun, P Gehlbach, M Melia, D Pieramici, JB Harlan, PA Campochiaro, DJ Zack
American Journal of Ophthalmology 2004
Effects of Growth-Factor Combinations on Vascular Endothelial Cell Growth In Vitro
WC Wu, YH Kao, CH Chung
Journal of Ocular Pharmacology and Therapeutics 2004
The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients
J Frystyk, T Bek, A Flyvbjerg, C Skjaerbaek, H Orskov
Diabetic Medicine 2003
Surgical Management of Diabetic Traction Retinal Detachment:
R Sarrafizadeh, CE Martin
Techniques in Ophthalmology 2003
Characterization of insulin signaling in rat retina in vivo and ex vivo
CE Reiter, L Sandirasegarane, EB Wolpert, M Klinger, IA Simpson, AJ Barber, DA Antonetti, M Kester, TW Gardner
American journal of physiology. Endocrinology and metabolism 2003
Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy
R Simó, A Lecube, RM Segura, JG Arumí, C Hernández
American Journal of Ophthalmology 2002
Antiangiogenic effects of somatostatin analogues
NG de la Torre, JA Wass, HE Turner
Clinical Endocrinology 2002
The pathogenesis of diabetic retinopathy: old concepts and new questions
J Cai, M Boulton
Eye 2002
The Endocrine System in Diabetes Mellitus
H Alrefai, H Allababidi, S Levy, J Levy
Endocrine 2002
Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation
BJ DeBosch, E Baur, BK Deo, M Hiraoka, AK Kumagai
Journal of Neurochemistry 2001
The place of pegvisomant in the management of acromegaly
C Parkinson, PJ Trainer
Expert Opinion on Investigational Drugs 2001
Acute effects of insulin on aqueous humor flow in patients with type 1 diabetes
JT Lane, CB Toris, SN Nakhle, DM Chacko, YL Wang, ME Yablonski
American Journal of Ophthalmology 2001
Transjugular intrahepatic portosystemic stent-shunt insufficiency and the role of diabetes mellitus
SH Shah, HF Lui, R Jalan, A Helmy, DN Redhead, K Penny, PC Hayes
European Journal of Gastroenterology & Hepatology 2001
Systemically Expressed Soluble Tie2 Inhibits Intraocular Neovascularization
M Hangai, YS Moon, N Kitaya, CK Chan, DY Wu, KG Peters, SJ Ryan, DR Hinton
Human Gene Therapy 2001
Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma1 1The authors do not have any proprietary or financial interest in any products or devices discussed in this study
JA Sivak-Callcott, DM O’Day, JD Gass, JC Tsai
Ophthalmology 2001
Physical Growth and Retinopathy in Preterm Infants: Involvement of IGF-I and GH
S Hikino, K Ihara, J Yamamoto, Y Takahata, H Nakayama, N Kinukawa, Y Narazaki, T Hara
Pediatric Research 2001
Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation: IGF-1 effects on retinal endothelial cells
BJ DeBosch, E Baur, BK Deo, M Hiraoka, AK Kumagai
Journal of Neurochemistry 2001
VLF: un nuevo activador no convencional de la vía del calcio aislado del humor vítreo
JP Camiña, E Díaz-Rodríguez, X Casabiell, M Lage, FF Casanueva
Endocrinología y Nutrición 2001
Role of tissue growth factors in aqueous humor homeostasis:
U Welge-Lüßen, CA May, AS Neubauer, S Priglinger
Current Opinion in Ophthalmology 2001
Vaskuläre Veränderungen bei der diabetischen Retinopathie: Die zellulären und humoralen Interaktionsmechanismen in Antwort auf die Stoffwechselveränderungen
AM Joussen, AP Adamis, B Kirchhof
Spektrum der Augenheilkunde 2000
Ocular angiostatic agents
AF Clark, DP Bingaman, MA Kapin
Expert Opinion on Therapeutic Patents 2000
Insulin-Like Growth Factor-I in Diabetes Mellitus: Its Physiology, Metabolic Effects, and Potential Clinical Utility
KM Thrailkill
Diabetes Technology & Therapeutics 2000
Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy
H Aksoy, F Akçay, N Kurtul, O Baykal, B Avci
Clinical Biochemistry 2000
Diabetic retinopathy: Some cellular, molecular and therapeutic considerations
DB Archer
Eye 1999
Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor
LE Smith, W Shen, C Perruzzi, S Soker, F Kinose, X Xu, G Robinson, S Driver, J Bischoff, B Zhang, JM Schaeffer, DR Senger
Nature Medicine 1999
Reduced Retinal Vascularization in Children with Growth Hormone Deficiency1
A Hellström, E Svensson, B Carlsson, A Niklasson, K Albertsson-Wikland
The Journal of clinical endocrinology and metabolism 1999
Increased Vitreous Concentrations of Human Hepatocyte Growth Factor in Proliferative Diabetic Retinopathy1
M Nishimura, T Ikeda, M Ushiyama, A Nanbu, S Kinoshita, M Yoshimura
The Journal of clinical endocrinology and metabolism 1999
Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma
RC Tripathi, J Lixa, BJ Tripathi, KV Chalam, AP Adamis
Ophthalmology 1998
Increased Serum Concentrations of Human Hepatocyte Growth Factor in Proliferative Diabetic Retinopathy
M Nishimura, K Nakano, M Ushiyama, A Nanbu, K Ohtsuka, H Takahashi, M Yoshimura
The Journal of clinical endocrinology and metabolism 1998
Insulin-like growth factors and their binding proteins in the developing eye
TJ Schoen, GJ Chader
Progress in Retinal and Eye Research 1997
Growth factors and their receptors in the retina and pigment epithelium
H Tanihara, M Inatani, Y Honda
Progress in Retinal and Eye Research 1997
Does IGF-I therapy in insulin-dependent diabetes mellitus limit complications?
N Møller, H Ørskov
The Lancet 1997
The Biology of Vascular Endothelial Growth Factor
N Ferrara, T Davis-Smyth
Endocrine reviews 1997
Molecular analysis of blood vessel formation and disease
N Ferrara
The American journal of physiology 1997
Insulin-like Growth Factor-1 Retinal Microangiopathy in the Pig Eye
RP Danis, DP Bingaman
Ophthalmology 1997
IGF-binding protein-2 is induced during development of urinary bladder hypertrophy in the diabetic rat
Y Chen, B Gustafsson, HJ Arnqvist
American journal of physiology. Endocrinology and metabolism 1997
Dual Hormonal Replacement Therapy with Insulin and Recombinant Human Insulin-Like Growth Factor (IGF)-I in Insulin-Dependent Diabetes Mellitus: Effects on the Growth Hormone/IGF/IGF-Binding Protein System*
K Thrailkill, T Quattrin, L Baker, J Litton, K Dwigun, M Rearson, M Poppenheimer, D Kotlovker, D Giltinan, N Gesundheit, P Martha
The Journal of clinical endocrinology and metabolism 1997
Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization
LE Smith, JJ Kopchick, W Chen, J Knapp, F Kinose, D Daley, E Foley, RG Smith, JM Schaeffer
Science 1997
Soluble adhesion molecules in NIDDM: Increased concentration, relation to glycometabolic control and possible pathophysiological significance
M Steiner, KM Reinhardt, AD Blann
Diabetologia 1996
DIABETIC EYE DISEASE
LP Aiello, J Cavallerano, SE Bursell
Endocrinology & Metabolism Clinics of North America 1996
Immunohistochemical distribution of basic fibroblast growth factor in experimental retinal ischaemia and reperfusion in the rat
A Ohira, E Juan, Y Tano, CA Wilson
The Histochemical Journal 1996
Diabetic Traction Retinal Detachment
D Eliott, T Hemeida
International Ophthalmology Clinics
Isolation and characterization of vitreous insulin-like growth factor binding proteins
C Guidry, JL King
Investigative ophthalmology & visual science 2011
Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far
W Whitmire, MM Al-Gayyar, M Abdelsaid, BK Yousufzai, AB El-Remessy
Molecular vision 2011
Proliferative diabetic retinopathy in acromegaly
C Malhotra
Oman journal of ophthalmology 2010
Analysis of candidate genes for macular telangiectasia type 2
NL Parmalee, C Schubert, JE Merriam, K Allikmets, AC Bird, MC Gillies, T Peto, M Figueroa, M Friedlander, M Fruttiger, J Greenwood, SE Moss, LE Smith, C Toomes, CF Inglehearn, R Allikmets
Molecular vision 2010
Growth hormone-activated STAT5 may indirectly stimulate IGF-I gene transcription through HNF-3{gamma}
S Eleswarapu, X Ge, Y Wang, J Yu, H Jiang
Molecular Endocrinology 2009
IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth
C Lofqvist, J Chen, KM Connor, AC Smith, CM Aderman, N Liu, JE Pintar, T Ludwig, A Hellstrom, LE Smith
Proceedings of the National Academy of Sciences 2007
The role of growth factors in the pathogenesis of diabetic retinopathy
MB Grant, A Afzal, P Spoerri, H Pan, LC Shaw, RN Mames
Expert Opinion on Investigational Drugs 2004
Insulin-Like Growth Factor-I Plays a Pathogenetic Role in Diabetic Retinopathy
V Poulaki, AM Joussen, N Mitsiades, CS Mitsiades, EF Iliaki, AP Adamis
The American Journal of Pathology 2004
Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor
V Stellmach, SE Crawford, W Zhou, N Bouck
Proceedings of the National Academy of Sciences 2001
Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management
M Boulton, Z Gregor, D McLeod, D Charteris, J Jarvis-Evans, P Moriarty, A Khaliq, D Foreman, D Allamby, B Bardsley
The British journal of ophthalmology 1997
Insulin-like growth factor binding protein production in bovine retinal endothelial cells
S Giannini, B Cresci, C Manuelli, Y Fujita-Yamaguchi, P Romagnani, S Mohan, CM Rotella
Metabolism 1997
Vascularised vitreoretinopathy: The role of growth factors
ME Boulton, D Foreman, D McLeod
Eye 1996
Early photocoagulation in patients with either type I or type II diabetes
F Ferris
Transactions of the American Ophthalmological Society 1996
Potential mechanisms promoting restenosis in diabetic patients
D Aronson, Z Bloomgarden, EJ Rayfield
Journal of the American College of Cardiology 1996
Insulin-like growth factor bioactivity and its modification in growth hormone resistant states
AJ Donaghy, RC Baxter
Baillière's Clinical Endocrinology and Metabolism 1996
Induction of Vascular Endothelial Growth Factor by Insulin-like Growth Factor 1 in Colorectal Carcinoma
RS Warren, H Yuan, MR Matli, N Ferrara, DB Donner
The Journal of biological chemistry 1996
Regulation of Angiogenesis
ID Goldberg, EM Rosen
1996
Immunohistochemical distribution of basic fibroblast growth factor in experimental retinal ischaemia and reperfusion in the rat
A Ohira, , Y Tano, CA Wilson
The Histochemical Journal 1996
The role of growth factors in the development of diabetic retinopathy
PS Sharp
Metabolism 1995
Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects
EJ Battegay
Journal of Molecular Medicine 1995
Vascular Endothelial Growth Factor -- Its Role in Retinal Vascular Proliferation
RN Frank
New England Journal of Medicine 1994
Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene
J Eggenschwiler, T Ludwig, P Fisher, PA Leighton, SM Tilghman, A Efstratiadis
Nature 1994
Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene
J Eggenschwiler, T Ludwig, P Fisher, PA Leighton, SM Tilghman, A Efstratiadis
Nature 1994
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
LP Aiello, RL Avery, PG Arrigg, BA Keyt, HD Jampel, ST Shah, LR Pasquale, H Thieme, MA Iwamoto, JE Park
American Journal of Ophthalmology 1994
Diabetic Retinopathy
FH Epstein, TJ Merimee
New England Journal of Medicine 1990
Current Management of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy:
JE Annan, PE Carvounis
International Ophthalmology Clinics
Functional and Molecular Characterization of Ex Vivo Cultured Epiretinal Membrane Cells from Human Proliferative Diabetic Retinopathy
Z Veréb, X Lumi, S Andjelic, M Globocnik-Petrovic, M Urbancic, M Hawlina, A Facskó, G Petrovski
BioMed Research International 2013
Vitreous levels of insulin-like growth factor-I in patients with proliferative diabetic retinopathy
N Inokuchi, T Ikeda, Y Imamura, C Sotozono, S Kinoshita, Y Uchihori, K Nakamura
Current Eye Research 2001
The Role of Growth Hormone in the Pathogenesis of Vascular Complications of Diabetes Mellitus
HU Rehman
The American Journal of the Medical Sciences 2000
Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor Are Present in Epiretinal and Choroidal Neovascular Membranes
RN Frank, RH Amin, D Eliott, JE Puklin, GW Abrams
American Journal of Ophthalmology 1996
The effect of scatter laser photocoagulation on intravitreal levels of growth factors in the miniature pig
M Xiao, A Khaliq, P Moriarty, D McLeod, J Cranley, M Boulton
Current Eye Research 1996
Obesity and Diabetes
M Smith, R Levine
Medical Clinics of North America 1964

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
50 readers on Mendeley
See more details